VaxInnate Corporation Licenses Recombinant Flu Vaccines to CJ CheilJedang of South Korea

CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation announced today that it has granted biopharmaceutical company CJ CheilJedang Corporation an exclusive license to manufacture, develop and commercialize VaxInnate’s recombinant seasonal and pandemic flu vaccines in South Korea. The agreement also includes a non-exclusive license to market the vaccines in certain Southeast Asian countries, excluding China.